Setsuo Hirohashi

发表

Ambition by the Officers of the Every Division of the 20th Term of SCJ

Norihisa Doi, Masaru Kono, Hideaki Karaki, 2005 .

The Proteomic Profile of Pancreatic Cancer Cell Lines Corresponding to Carcinogenesis and Metastasis

Tadashi Kondo, Kiyonaga Fujii, Setsuo Hirohashi, 2009 .

A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer.

Hideo Tanaka, Yusuke Nakamura, Yeon-Su Lee, 2011, Gastroenterology.

Actinin-4, a Novel Actin-bundling Protein Associated with Cell Motility and Cancer Invasion

Hitoshi Tsuda, Ritsuko Endo, Setsuo Hirohashi, 1998, The Journal of cell biology.

Altered Expression of the ERM Proteins in Lung Adenocarcinoma

Michiie Sakamoto, Setsuo Hirohashi, Toshiro Niki, 2000, Laboratory Investigation.

Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells.

Michiie Sakamoto, Setsuo Hirohashi, Jun Yasuda, 2003, Biochemical and biophysical research communications.

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

Yasuo Ohashi, Michiie Sakamoto, Tadatoshi Takayama, 2000, The Lancet.

Clinicopathological significance of nuclear factor‐κB activation in hepatocellular carcinoma

Michiie Sakamoto, Toshiya Kamiyama, Setsuo Hirohashi, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas.

Miyuki Saito, Setsuo Hirohashi, Jun Yokota, 2002, The American journal of pathology.

Krüppel‐like factor 12 plays a significant role in poorly differentiated gastric cancer progression

Misao Ohki, Kengo Takeuchi, Yasuhito Arai, 2009, International journal of cancer.

Tsutomu Ohta, Koji Tsuta, Hisao Asamura, 2008, Proceedings of the National Academy of Sciences.

Pathology of small hepatocellular carcinoma. A proposal for a new gross classification

Noriyuki Moriyama, Setsuo Hirohashi, Hiroshi Hasegawa, 1987, Cancer.

Proteomic signature of human cancer cells

Tadashi Kondo, Shoji Kudoh, Setsuo Hirohashi, 2004, Proteomics.

Label-free Quantitative Proteomics Using Large Peptide Data Sets Generated by Nanoflow Liquid Chromatography and Mass Spectrometry*

Setsuo Hirohashi, Tesshi Yamada, S. Hirohashi, 2006, Molecular & Cellular Proteomics.

Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma.

Tsutomu Ohta, Michiie Sakamoto, Setsuo Hirohashi, 2004, Journal of hepatology.

CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis.

Setsuo Hirohashi, Yae Kanai, Tesshi Yamada, 2011, Gastroenterology.

Global Protein-expression Analysis of Bone and Soft Tissue Sarcomas

Kazutaka Kikuta, Tadashi Kondo, Akira Kawai, 2008, Clinical orthopaedics and related research.

Growth and spread of hepatocellular carcinoma: A review of 240 consecutive autopsy cases

Michiie Sakamoto, Setsuo Hirohashi, S. Hirohashi, 1990, Cancer.

Alternative splice variant of actinin-4 in small cell lung cancer

Tadashi Kondo, Setsuo Hirohashi, Tesshi Yamada, 2004, Oncogene.

Possible detection of pancreatic cancer by plasma protein profiling.

Tomoko Umaki, Tatsuya Aoki, Satoru Kikuchi, 2005, Cancer research.

Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy.

Masahiko Miura, Hitoshi Tsuda, Setsuo Hirohashi, 2002, Cancer research.

Survival Prediction for Pancreatic Cancer Patients Receiving Gemcitabine Treatment*

Yoshiro Saito, Hideki Ueno, Koh Furuta, 2010, Molecular & Cellular Proteomics.

Overexpression of KIT in chromophobe renal cell carcinoma

Tsutomu Ohta, Misao Ohki, Michiie Sakamoto, 2003, Oncogene.

Small adenocarcinoma of the lung. Histologic characteristics and prognosis

Setsuo Hirohashi, Tesshi Yamada, Yoshihiro Matsuno, 1995 .

Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer

Yusuke Nakamura, Yeon-Su Lee, Yasunori Sato, 2008, Nature Genetics.

Regulation of Wnt signaling by the nuclear pore complex.

Setsuo Hirohashi, Tesshi Yamada, S. Hirohashi, 2008, Gastroenterology.

Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection

Michiie Sakamoto, Tadatoshi Takayama, Setsuo Hirohashi, 1996, Cancer.

CD44 variant exon 6 expressions in colon cancer assessed by quantitative analysis using real time reverse transcriptase-polymerase chain reaction.

Hisashi Narimatsu, Setsuo Hirohashi, S. Hirohashi, 2003, Oncology reports.

Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic β-catenin protein

Tadashi Kondo, Setsuo Hirohashi, Kohzoh Imai, 2005, Oncogene.

Wnt signaling inside the nucleus

Setsuo Hirohashi, Tesshi Yamada, S. Hirohashi, 2008, Cancer science.

Overexpression of Cyclase-Associated Protein 2 in Multistage Hepatocarcinogenesis

Michiie Sakamoto, Setsuo Hirohashi, Makoto Chuma, 2006, Clinical Cancer Research.

Possible Prediction of Chemoradiosensitivity of Esophageal Cancer by Serum Protein Profiling

Tomoko Umaki, Tatsuya Aoki, Setsuo Hirohashi, 2005, Clinical Cancer Research.

Proteomic signatures for histological types of lung cancer

Tadashi Kondo, Shoji Kudoh, Setsuo Hirohashi, 2005, Proteomics.

Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.

Tsutomu Ohta, Misao Ohki, Michiie Sakamoto, 2003, The American journal of pathology.

Application of sensitive fluorescent dyes in linkage of laser microdissection and two‐dimensional gel electrophoresis as a cancer proteomic study tool

Tadashi Kondo, Setsuo Hirohashi, Tesshi Yamada, 2003, Proteomics.

Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

Tadashi Kondo, Toshihide Nishimura, Kiyonaga Fujii, 2007, Clinical Cancer Research.

Dysadherin: a new player in cancer progression.

Setsuo Hirohashi, S. Hirohashi, L. Wakefield, 2007, Cancer letters.